ProSomnus non-inferior to CPAP therapy for the treatment of moderate to severe OSA
The First Line Obstructive Sleep Apnea Treatment study (FLOSAT) clinical trial assessing ProSomnus, a CPAP alternative for the treatment...
top of page
Browse by category
Search
Increased cardiovascular risks for people with obstructive sleep apnoea
Researchers have found that people with have an increased cardiovascular risk due to reduced blood oxygen levels, largely explained by...
Obstructive sleep apnoea could directly cause early cognitive decline
Researchers from the UK, Germany, and Australia have shown for the first time that obstructive sleep apnoea (OSA) in middle-aged men can...
Guy’s and St Thomas’ first in the UK to provide new sleep apnoea treatment
Guy’s and St Thomas’ has become the first NHS trust in the UK to use a pioneering implant device to treat severe sleep apnoea....
Journal Watch 14/12/2022
Welcome to our weekly round-up of the latest bariatric and obesity-related papers published in the medical literature. As ever, we have...
Browse by tag
bottom of page